<p>Incidence and PD-L1 Expression of <em>MET</em> 14 Skipping in Chinese Population: A Non-Selective NSCLC Cohort Study Using RNA-Based Sequencing</p>

Abstract

The prevalence of <i>MET</i> exon14 skipping in lung ADCs in the East Asian population was similar to that of the Western population as assessed by RNA-based NGS. The NSCLC patients with <i>MET</i> exon 14 skipping were older than those with other oncogenic driver mutations, such as <i>EGFR, ALK</i>, and <i>ROS1</i>. In addition, PD-L1 was highly expressed in NSCLC patients with <i>MET</i> exon 14 skipping.